Summary: Anoxic depolarization (AD) and failure of ion homeostasis play an important role in ischemia-induced neuronal injury. In the present study, different drugs with known ion-channel-modulating properties were examined for their ability to interfere with cardiac-arrest-elicited AD and with the changes in the extracellular ion activity in rat brain. Our results indicate that only drugs primarily blocking membrane Na + permeability (NBQX, R56865, and flunarizine) delayed the occurrence of AD, while compounds affecting cellular Ca 2 + load (MK-801 and nimodipine) did not influence the latency time. The ischemia-induced [Na +]e reduction was attenuated by Anoxic depolarization (AD) is a well known phe nomenon occurring if tissue energy supply ceases for a certain time. The normal compartmentation of ions between the intra-and extracellular space breaks down and the cerebral direct current (DC) potential exhibits a sudden negative shift (Hansen, 1985) . Previous studies have shown that the sever ity of the ischemic neuronal injury was significantly correlated with the time period during which the brain tissue was in a depolarized state (Balestrino et ai., 1989; Somjen et ai., 1990; Gill et ai., 1992). Some drugs beneficial in the treatment of cerebral ischemia are able to delay the occurrence of AD (Balestrino and Somjen, 1986; Holler et ai., 1986). Therefore, the latency from onset of ischemia until occurrence of AD has been considered an indicator for the tissue resistance against ischemic insults (Bures and Buresova, 1957) .
Anoxic depolarization (AD) is a well known phe nomenon occurring if tissue energy supply ceases for a certain time. The normal compartmentation of ions between the intra-and extracellular space breaks down and the cerebral direct current (DC) potential exhibits a sudden negative shift (Hansen, 1985) . Previous studies have shown that the sever ity of the ischemic neuronal injury was significantly correlated with the time period during which the brain tissue was in a depolarized state (Balestrino et ai., 1989; Somjen et ai., 1990; Gill et ai., 1992) . Some drugs beneficial in the treatment of cerebral ischemia are able to delay the occurrence of AD (Balestrino and Somjen, 1986; Holler et ai., 1986) . Therefore, the latency from onset of ischemia until occurrence of AD has been considered an indicator for the tissue resistance against ischemic insults (Bures and Buresova, 1957) .
However, for an effective search of antiischemic drugs and to get a plausible explanation of the drug R56865. Blockade of the ATP-sensitive K + channels with glibenclamide reduced the [K +]e increase upon ischemia, indicating an involvement of the KATP channels in isch emia-induced K + efflux. The KATP channel opener cro makalim did not affect the AD or the [K +]e concentra tion. The ischemia-induced rapid decline of extracellular calcium was attenuated by receptor-operated Ca 2 + chan nel blockers MK-801 and NBQX, but not by the voltage operated Ca 2 + channel blocker nimodipine, R56865, and flunarizine. Key Words: Anoxic depolarization Calcium-Cerebral ischemia-Cerebral pharmacology Ion homeostasis.
properties needed to delay the occurrence of AD, better understanding of this phenomenon is re quired. A primary event upon cerebral ischemia preceding and coinciding with AD is the change in membrane ion permeability. The present study is an attempt to investigate which types of ion channels are involved before, during, and after the negative DC shift and whether the ischemia-induced ion movements influence the latency time from onset of ischemia until the occurrence of AD. For this pur pose, we examined the effects of selected com pounds with known ion-channel-modulating proper ties in a rat model of global cerebral ischemia in duced by cardiac arrest.
MATERIALS AND METHODS

Animal preparation
Male Wi star rats (230-280 g body wt) were anesthetized by intraperitoneal injection of urethane 0.2-2.0 glkg).
Femoral artery and vein were cannulated to monitor ar terial blood pressure, collect blood samples, and apply drugs. The rectal temperature was kept at 37.5°C by means of a warm water blanket surrounding the' animal body. The animals were immobilized by intravenous in jection of succinylcholine and artificially ventilated with 0 2 /N 2 (30:70) gas mixture. A hole of 3-mm diameter was drilled in the parietal skull. A double-or triple-barrel glass electrode was inserted into the cortex at I-mm depth. In the majority of the experiments, the animals received a to-min lasting intravenous infusion of drugs or the same volume (=0.5 ml) of solvents. Glibenclamide and cro makalim were applied locally for 60 min on the cortical surface by using a superfusion technique. In this case, the drugs were dissolved in artificial CSF at a concentration of 50 j.LM and the brain surface exposed by the craniec tomy was covered with this solution. A pump delivered continuously 1 j.LVmin fresh drug solution to the brain surface to compensate for evaporation. The control ani mals received CSF superfusion without drug. In Table 1 the examined compounds, the dosage used, and the cor responding solvents are presented. Cardiac arrest was in duced by intravenous injection of saturated MgCl 2 30 min after the beginning of the intravenous drug treatment or 60 min after the beginning of the superfusion.
Chemicals
NBQX was a gift from Novo Nordisk (Bagsvaerd, Den mark). MK-801 and glibenclamide were purchased from Research Biochemicals (Natick, MA, U.S.A.). Nimo dipine was obtained from Bayer AG (Leverkusen, Ger many) and cromakalim from Beecham Pharmaceuticals (Surrey, U.K.). R56865 and flunarizine were delivered by the Janssen Research Foundation (Beerse, Belgium).
The organic ionophores for the measurement of ion ac tivities with ion-sensitive microelectrodes were pur chased from Fluka (Neu-Ulm, Germany). Other chemi cals and reagents, if not otherwise stated, were obtained from Merck (Darmstadt, Germany).
Monitoring techniques
The arterial Po 2 , Pco 2 , and blood pH values were mon itored by means of a blood gas analyzer (Eschweiler, Kiel, Germany) . Glibenclamide concentration in the cor tical tissues was determined by a modified HPLC method described by Wahlin-Boll and Melander (1979) . The ion sensitive barrels of the micro electrode were filled alter natively with different organic ionophores. The cortical DC potential was recorded as the potential difference be tween the reference barrel of the microelectrode and an extracranially located Ag/AgCI electrode. The potential difference between the ion-sensitive and the reference barrels reflected the extracellular ion activity. The micro electrodes were calibrated in artificial CSFs containing different concentrations of the corresponding ions before and after each individual experiment.
The latency (s) to AD was assessed by measuring the time period from induction of the cardiac arrest to the sudden negative deflection of the extracellular DC poten tial. The measurement of the amplitude (mY) of AD is illustrated in Fig. 1 . The extracellular K + concentration (mM) from which [K + le starts to rise rapidly during isch emia was defined as K + threshold (arrow in Fig. 1 ). The maximal [K + le concentration and the final (lowest) [Ca 2 +1e and [Na +le concentrations were determined -5 min after occurrence of AD.
Statistics
The values measured in the drug-treated groups were compared with the control values by using one-way fac torial analysis of variance and sequential Dunnett t test for multiple comparison of independent samples (two tailed). p < 0.05 was considered significant.
RESULTS
Control animals
Control animals treated individually with differ ent solvents did not show any significant differ ences in all measured parameters. Therefore, the results from these animals were pooled into one control group for further analysis.
General physiological variables
The arterial blood Po2, Peol> and pH were kept within the normal range during the experiments (Ta ble 2). At the dosages used, nimodipine, flunarizine, and R56865 reduced the arterial blood pressure, whereas NBQX and systemic application of glib enclamide increased the blood pressure slightly (Ta ble 2). Heart rate was significantly accelerated by NBQX and slowed down by R56865 and flunarizine ( Table 2 ). The ECG morphology was normal and unchanged.
Responses of cortical DC potential to cerebral ischemia
After an initial small positive shift, the cortical DC potential exhibited a sudden negative deflection (AD) upon cerebral ischemia ( 
cardiac arrest until the DC negative shift ranged from 80 to 150 s (mean 130. 2 s). Table 3 summarizes the effects of different drugs on ischemia-induced AD. Three compounds significantly prolonged the latency to AD: NBQX by 34%, flunarizine by 24% , and R56865 by 26%. Combined treatment with NBQX plus MK-801 showed a similar result (30% increase) as when NBQX was used alone. Systemic application of 5 mg/kg glibenclamide shortened the latency to AD by 25% . This effect was not observed when glibenclamide was applied locally, although both kinds of treatment resulted in a similar drug tissue concentration (15. 6 ng/g in intravenous and 12. 5 ng/g in superfusion group, respectively). The amplitude of the DC negative shift was not influ enced by any of the drugs used (Table 3) . Immediately after the onset of cerebral ischemia, there was a transient [K +]e elevation to 4 mM. The [K +]e usually declined again and was followed by a secondary slow elevation to the so-called K + threshold from which the extracellular potassium concentration rose steeply (Fig. O Values are means ± SD. The MABP and heart rate were measured 10 min prior to and 10 min after the drug treatment. The blood gas values were obtained just before induction of cardiac arrest. a p < 0.05 (difference before and after treatment, paired t test). The maximal [K +]e during ischemia was also re duced after both glibenclamide treatments (Table  4 ). All other compounds slightly increased [K +]e threshold. However, this effect failed to reach sta tistical significance when one-way factorial analysis of variance and the multiple comparison test were used (Table 4) .
The change of [Ca 2 +]e upon cerebral ischemia was triphasic (Fig. 1) . It exhibited at first an initial elevation from 1.09 ± 0.1 to 1.28 ± 0.1 mM. At the beginning of the negative DC deflection, the [Ca 2 +]e dropped rapidly to �0.25 mM and subse quently declined slowly to the final level of 0.07 ± 0.03 mM measured at 5 min after AD (Table 4) . Neither the final [Ca 2 +]e concentration during isch emia nor the speed of the rapid [Ca 2 +]e reduction was affected by any of the tested compounds. How ever, the ischemia-induced [Ca 2 +]e reduction was slowed down by both glutamate antagonists MK-801 and NBQX, which was revealed by the mea surement of time to the 90% reduction of [Ca 2 +]e ( Fig. 2; Table 4 ).
The [Na +]e activity was recorded only in control animals and animals treated with NBQX and R56865. The ischemia-induced [Na +]e changes re sembled the [Ca 2 +]e profile. It exhibited an initial minor elevation and a rapid fall associated with AD (Fig. 1) . The final minimal [Na +]e concentration measured at 5 min after AD was 53.3 ± 5.3 mM in the control group (Table 4) . R56865 (5 mg/kg) sig nificantly increased the final [Na+]e to 65.9 ± 4.9 mM, whereas the NBQX treatment (30 mg/kg) did not show a clear effect (Table 4) . We also treated two animals with 60 mg/kg NBQX. The minimal [Na +]e concentrations during ischemia in these two animals were both >70 mM and markedly higher J Cereb Blood Flow Metab, Vol. 15, No.4, 1995 than the level of 53 mM measured in the control animals (Table 4) .
DISCUSSION Resistance to ischemic AD
In the present study, three of the seven com pounds tested were able to delay the occurrence of AD upon cerebral ischemia. These compounds, NBQX, flunarizine, and R56865, have all been proven to block membrane Na + fluxes. NBQX is a selective antagonist of the glutamate receptor of the AMPA subtype (Watkins et aI., 1990) . The AMPA receptor-regulated ion channels have been shown to be predominantly permeable to sodium ions (Young and Fagg, 1990) . Flunarizine and R56865 have been characterized as Na + /Ca 2 + overload blockers (Pau wels et aI., 1991). They block not only the voltage dependent Ca 2 + channels, especially the T and N type (Takahashi et aI., 1989; Panchenko et aI., 1993) , but also the voltage-dependent Na + channel (Kiskin et aI., 1993) . In contrast, the drugs that prin cipally interfere only with transmembrane Ca 2 + movement like MK-801 [N-methyl-D-aspartate (NMDA) antagonist] and nimodipine (L-type Ca 2 + channel blocker) did not influence the latency time to AD. At the dosage used, the ATP-sensitive K + channel modulators (glibenclamide and cro makalim) did not affect the latency time to AD. Thus, it seems reasonable to assume that the isch emia-induced Na + influx is the major factor in de termining the latency time from onset of ischemia to the occurrence of AD.
AD and Na+ fluxes
In previous studies it was shown that ischemia caused an early Na + influx preceding the complete breakdown of ion homeostasis (Jiang et aI., 1992a) . This early Na + influx was strongly inhibited by te trodotoxin (TTX) , and the latency time to the oc currence of AD was enormously prolonged (Xie et aI., 1994) . The prolonged onset time to AD ob served in the present study suggested that the isch emia-induced early Na + influx could also be inhib ited by R56865, flunarizine, and NBQX. In other words, both voltage-and receptor-operated Na + channels may be involved in the ischemia-induced early Na + influx. The linkage between the Na + blocking effect and the prolongation of the latency time to AD is probably an energy-saving mecha nism. The transmembranal Na + gradient is main tained by the Na + /K + pump at the expense' of en ergy. Previous studies showed that the DC negative deflection occurred in the rat brain when the tissue A TP content was reduced to 30% of the normal level (Obrenovitch et aI., 1990) . Comparative stud ies demonstrated that the brain ischemia tolerance (maintenance of the cellular ion homeostasis) was clearly dependent on the preservation of energy (Doll et aI., 1991; Xia et aI., 1992) . A limited Na+ influx will reduce the mismatch between cellular metabolic demand and energy supply and thereby delay the occurrence of AD. In fact, it has been shown that TTX was able to slow down the isch emia-induced ATP fall (Boening et al., 1989) . Our results are also in line with this hypothesis. The massive Na + movement coinciding with the AD, evidenced by the rapid [Na +]e fall from 135 to 53 mM, was only marginally affected by the drugs. Even at a very high dose (10 j..l M), TTX did not influence the ischemia-induced [Na +]e fall, indicat ing that the voltage-dependent Na + channels may not be essential in this process (Xie et aI., 1994) .
The AMPA receptor antagonist NBQX seemed to attenuate the [N a +]e decline at a high dose of 60 mg/kg (see Results), implying a possible involve ment of the receptor-operated Na + channels in the rapid redistribution of Na + ions coinciding with the AD.
An intriguing finding is that the rapid [Na +]e de crease associated with AD was slightly, but never theless significantly, attenuated by R56865, while the strong Na + channel blocker TTX was ineffec tive (Xie et aI., 1994) . Which channels did R56865 block? Recent studies using patch clamp and fluo rescence techniques showed that the Na + blockade effect of R56865 differed principally from that of TTX (Verdonck et aI., 1990; Kiskin et aI., 1993) . R56865 preferably affected the open Na + channels and enhanced the inactivation process irreversibly. R56865 also increased the cell membrane resistance and reduced the leakage current (Kiskin et aI., 1993) . These effects can be enhanced by ischemic conditions. Accordingly, the R56865 effect ob served in the present study might suggest that the nonspecific cation pathway (carrier of the leakage current? ) becomes dominant for Na + movement af ter massive cell depolarization and/or the voltage operated Na + channels undergo certain modifica tions upon ischemia that makes them more sensitive to R56865 than to TTX.
AD and ATP-sensitive K + (KATP) channels
Another important factor regulating cell mem brane potential is the K + permeability. Previous studies have shown that a blockade of the ischemia induced K + efflux facilitated the AD (Ben-Ari, 1990; Jiang et aI., 1992b) . Several in vitro studies using cultured neurons or brain slices suggested that the KATP channel is intimately involved in me diating K + efflux under ischemic/anoxic conditions (Ben-Ari et aI., 1990; Jiang and Haddad, 1991) . The present data confirm these observations in in vivo experiments. Glibenclamide, a rather specific ligand and blocker for KATP channels, was able to curb the ischemia-induced [K +]e elevation in the cortex. The K + threshold was significantly lower in the glibenclamide-treated than in the control ani mals, while the AD latency remained unaffected. This indicates that the ischemia-induced potassium efflux is lowered when ATP-dependent potassium channels are blocked. In addition to this, the potas sium level measured after AD was lower than in controls (Table 4) . Thus, the KATP channels may mediate both the early slow K + efflux and the rapid transmembrane K + redistribution coinciding with the AD. A facilitation of AD (shortening of the la tency time to AD) was not observed in our experi ments.
There are conflicting data concerning the effects of K + channel blockers on cellular hyperpolariza tion. This may be due to the different preparations used. It is well known that cellular potassium efflux is clearly affected by the size of the extracellular space, which is larger in in vitro preparations than in vivo.
Since it is well known that glibenclamide affects the blood glucose at the intravenous dosage used in the present study, we administered the compound also locally via the cup technique. After either sys temic and local application, the glibenclamide con centration in the brain tissue and its effects on the ischemia-induced [K +]e changes were comparable (Table 4) . Therefore, it could be assumed that the effects on the extracellular K + levels observed in the present study may rather be mediated via its J Cereb Blood Flow Metab, Vol. 15, No.4, 1995 parenchymal effect in the brain than via possible systemic changes in the blood glucose concentra tion. However, the observed AD latency shortage in the animals receiving glibenclamide intrave nously (Table 3) can be at least partly explained by the reduced plasma glucose content (Hansen, 1978) , which did not occur if the drug was applied locally. Since only a single dose of glibenclamide was used, we cannot exclude that this dosage might have been too low to affect the AD latency directly.
Opening KATP channels hyperpolarizes the mem brane potential and limits the neuronal excitability. Consequently, it should prevent or delay the AD and the subsequent deterioration (Duty and Wes ton, 1990; Miller, 1990; Murphy and Greenfield, 1991) . In animal experiments, the KATP channel opener aprikalim (RP52891) was used successfully to reduce myocardial infarct size (Grover et aI., 1990; Auchampach et aI., 1991) . In in vitro experi ments, the KATP channel openers have also been proven to antagonize anoxia-induced neuronal de polarization (Ben-Ari, 1990; Ben-Ari et aI., 1990) . In the present study, however, cromakalim treat ment did not delay the occurrence of the AD or influence the ischemia-induced K + efflux. In a pilot experiment, 5 mg/kg cromakalim given intrave nously was also ineffective (data not shown). The reason for this negative result may possibly be an inadequate dosage or application route. Cro makalim has been shown to be effective at doses ranging from 20 to 100 j.LM in brain slices (Alzhei mer et al., 1989) , but the tissue drug concentration in our experiments could not be determined. An other possible explanation is that the neuronal KATP channels are already maximally activated in car diac-arrest-induced cerebral ischemia. Thereafter, no further activation could be achieved by the drug. This consideration may be supported by the obser vation of Ripoll and colleagues (1990) . In their ex periments, the KATP-channel-activating effect of 40 j.LM cromakalim was lost if A TP was absent in the tissue bath.
AD and Ca 2 + fluxes
Our results showed that the ischemia-induced cortical [Ca 2 +]e decrease was slowed down by the glutamate receptor antagonists MK-801 and NBQX, while the voltage-operated Ca 2 + channel blockers nimodipine (L type), flunarizine, and R56865 (T and N type) were ineffective. This is in agreement with observations of other authors (Pluta et al., 1989; Silver and Erecinska, 1990; Salinska et aI., 1991) who also observed that the ischemia induced Ca 2 + influx cannot be blocked by voltage operated Ca 2 + channel blockers. The ineffective-ness of nimodipine, R56865, and flunarizine can probably be explained by the intrinsic electrophys iological properties of the voltage-operated calcium channels that undergo rapid inactivation upon cell depolarization. The receptor-operated ion chan nels, therefore, become the predominant pathway for Ca 2 + influx. Channels linked to glutamate re ceptors of NMDA subtype are well known to be more permeable to calcium ions than to sodium ions (Mayer and Miller, 1990) . Under ischemic condi tions, a persistent and pronounced activation of the NMDA receptors is favored by the increased extra cellular glutamate concentration (Beneveniste et aI., 1984) and the relief of the magnesium blockade by membrane depolarization (Mayer et aI., 1984) . The effect of AMPA receptor antagonist NBQX on ischemia-induced [CaH le decline could be ex plained in several ways. First, AMPA receptors promote the NMDA receptor activation by modu lating membrane potentials (Murphy and Miller, 1989; Collingride and Singer, 1990) . Second, the AMPA receptor-mediated Na + influx may reverse the Na + /CaH exchanger and lead to a secondary Ca 2 + influx (Waxman et aI., 1991) . Finally, there is increasing evidence indicating that the AMP A re ceptors per se can be permeable to calcium ions (Hollmann et aI., 1991) . Such calcium permeability of the AMPA receptor was already reported in cul tured hippocampal neurons (Lino et aI., 1990) and cerebellar glial cells (Burnashev et aI., 1992) . The effects of NBQX on ischemia-induced decrease of [Ca 2 +le observed in the present study may imply the existence of calcium-permeable AMP A recep tors in the cortical neurons and glial cells.
In summary, we demonstrated that the blockade of ischemia-induced Na + influx showed the most pronounced effect on the latency time to occur rence of AD. This effect may be the consequence of an energy-saving process. The KATP channels are present in the rat cortical nervous tissue. They are involved in the ischemia-induced K + efflux and may contribute to the development of AD. The ischemia-evoked Ca 2 + influx, mainly mediated by the receptor-operated but not the voltage-de pendent Ca 2 + channels, might not be the cause but rather the consequence of cell depolarization. Hence, attenuating cellular sodium overload might be the primary route to increase tissue resistance against ischemia/anoxia.
